Replies to post #2956 on Enanta Pharmaceuticals Inc (ENTA)

[dewophile]

re RSV polymerase inhibitor (EDP-323)

you want to stay a step ahead of competition.

Shionogi has an RSV polymerase inhibitor in a challenge study. There is also some color on ensitrelvir and the recent readout that missed the primary endpoint in the shionogi transcript for those interested

https://www.shionogi.com/content/dam/shionogi/global/investors/ir-library/presentation/2023/4q/e20240516.pdf